Becamon, Monaliza .
HRN: 22-90-39 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/01/2023
CO-AMOXICLAV 625MG (TAB)
05/01/2023
05/07/2023
ORAL
625 Mg
TID
S/P D And C
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes